The Clinical Supply Management (CSM) team at Catalent has developed a fact-based methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. To view this email as a web page,
click here
In a BioPharma Dive industry survey of 150+ individuals with responsibility for clinical supplies, planning and forecasting were identified as top concerns for trial sponsors and were seen as activities that can yield significant benefits. In response to this need, the Clinical Supply Management (CSM) team at Catalent has developed a factbased methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management. | |
|
|
You are currently subscribed as [email protected] If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe. Refer to our Privacy Policy. Fierce LifeSciences is a division of Questex LLC. 685 3rd Ave 21st Floor New York, NY 10017 © 2020 Questex LLC. All Rights Reserved. Reproduction in whole or in part is prohibited without written permission. | |